Business Description
Lumexa Imaging Holdings Inc
NAICS : 339112
SIC : 3845
ISIN : US5502491062
Total Employee Number:
4,335Description
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | 0.34 | |||||
Debt-to-Equity | 1.61 | |||||
Debt-to-EBITDA | 18.5 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 0.67 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Future 3-5Y Total Revenue Growth Rate Estimate | 5.13 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 91.72 | |||||
9-Day RSI | 83.07 | |||||
14-Day RSI | 74.75 | |||||
3-1 Month Momentum % | 5.28 | |||||
6-1 Month Momentum % | -54.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.4 | |||||
Quick Ratio | 1.4 | |||||
Cash Ratio | 0.32 | |||||
Days Sales Outstanding | 93.87 | |||||
Days Payable | 32.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | 19.61 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 14.78 | |||||
Operating Margin % | -0.57 | |||||
Net Margin % | -5.18 | |||||
EBITDA Margin % | 10.05 | |||||
FCF Margin % | 2.01 | |||||
OCF Margin % | 3.85 | |||||
ROE % | -5.98 | |||||
ROA % | -1.55 | |||||
ROIC % | -0.18 | |||||
ROC (Joel Greenblatt) % | 9.33 | |||||
ROCE % | 1.41 | |||||
Moat Score | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 16.01 | |||||
PS Ratio | 2.23 | |||||
PB Ratio | 1.94 | |||||
Price-to-Free-Cash-Flow | 111.01 | |||||
Price-to-Operating-Cash-Flow | 57.89 | |||||
EV-to-EBIT | 93.76 | |||||
EV-to-EBITDA | 39.75 | |||||
EV-to-Revenue | 4 | |||||
EV-to-FCF | 198.51 | |||||
Earnings Yield (Greenblatt) % | 1.07 | |||||
FCF Yield % | 0.9 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LMRI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lumexa Imaging Holdings Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 520.271 | ||
| EPS (TTM) ($) | -0.36 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 74.75 | ||
| 14-Day ATR ($) | 0.763869 | ||
| 20-Day SMA ($) | 9.0165 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 6.45 - 19.45 | ||
| Shares Outstanding (Mil) | 96.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lumexa Imaging Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lumexa Imaging Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2026 | 2026-08-31 | In 64 days | ||
| General meeting for 2025 | 2026-06-10 08:30 | 8.65 (+5.88%) | ||
| First quarter earnings conference call for 2026 | 2026-05-12 17:00 | 10.16 (-1.17%) | ||
| First quarter earnings results for 2026 | 2026-05-12 | 10.16 (-1.17%) | ||
| Annual report for 2025 | 2026-03-30 | 7.79 (+0.52%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-26 08:30 | 11.06 (+2.12%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-26 | 11.06 (+2.12%) | ||
| Barclays 28th Annual Global Healthcare Conference | 2026-03-10 15:30 | 14.73 (-1.21%) | ||
| Leerink Partners Global Healthcare Conference | 2026-03-09 08:40 | 14.80 (-5.25%) | ||
| Raymond James Institutional Investors Conference | 2026-03-02 15:25 | 14.14 (-0.42%) |
Show
Entries
Lumexa Imaging Holdings Inc Frequently Asked Questions
What is Lumexa Imaging Holdings Inc(LMRI)'s stock price today?
The current price of LMRI is $12.10. The 52 week high of LMRI is $19.45 and 52 week low is $6.45.
When is next earnings date of Lumexa Imaging Holdings Inc(LMRI)?
The next earnings date of Lumexa Imaging Holdings Inc(LMRI) is 2026-08-31 Est..
Does Lumexa Imaging Holdings Inc(LMRI) pay dividends? If so, how much?
Lumexa Imaging Holdings Inc(LMRI) does not pay dividend.
Guru Commentaries on NAS:LMRI
No articles.
Press Release
Articles on Lumexa Imaging Holdings Inc
No articles.